ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 32602015

Insulin growth factor-1 pathway in cervical carcinoma cancer stem cells.

Javed S and 3 others. Mol Cell Biochem, 2020. Cited by 10 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Insulin growth factor-1 pathway in cervical carcinoma cancer stem cells. Papers, record 32602015. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32602015

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Insulin growth factor-1 pathway in cervical carcinoma cancer stem cells.
PubMed
Journal
Mol Cell Biochem
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
0.53
iCite
Revised in PubMed
2026-10-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Javed SShifa
2Bhattacharyya SShalmoli
3Bagga RRashmi
4Srinivasan RRadhikahttps://orcid.org/0000-0002-1771-091X

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Epithelial-Mesenchymal TransitionMajor topic
Insulin-Like Growth Factor IMajor topic
Neoplasm ProteinsMajor topic
Signal TransductionMajor topic
Uterine Cervical NeoplasmsMajor topic
Cell Line, Tumor
Female
Humans
Neoplastic Stem Cells

Source PubMed

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
DST No: D.O. No.-SR/SO/HS-0166/2010Department of Science and Technology, Govt. of IndiaPubMed
ICMR-JRF-2012/HRD-139(10056)Indian Council of Medical Research Junior Research FellowshipsPubMed
71/5-EDU/12/1363PGI Intramural Research SchemePubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132,428,851IGF1R Axis Inhibition Restores Dendritic Cell Antitumor Response in Ovarian Cancer.Transl Oncol2020https://conductscience.org/library/papers/32428851PubMed
214,654,527Expression genomics of cervical cancer: molecular classification and prediction of radiotherapy response by DNA microarray.Clin Cancer Res2003https://conductscience.org/library/papers/14654527PubMed
318,781,172Clinical implications of insulin-like growth factor 1 system in early-stage cervical cancer.Br J Cancer2008https://conductscience.org/library/papers/18781172PubMed
425,123,819Can we unlock the potential of IGF-1R inhibition in cancer therapy?Cancer Treat Rev2014https://conductscience.org/library/papers/25123819PubMed
528,245,823The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer.Mol Cancer2017https://conductscience.org/library/papers/28245823PubMed
622,284,662Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance.BMC Cancer2012https://conductscience.org/library/papers/22284662PubMed
720,042,609
Mechano-transduction in osteoblastic cells involves strain-regulated estrogen receptor alpha-mediated control of insulin-like growth factor (IGF) I receptor sensitivity to Ambient IGF, leading to phosphatidylinositol 3-kinase/AKT-dependent Wnt/LRP5 receptor-independent activation of beta-catenin signaling.
J Biol Chem2010https://conductscience.org/library/papers/20042609PubMed
825,984,556Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance.Genes Dis2015https://conductscience.org/library/papers/25984556PubMed
930,847,042Recent Advances on the Molecular Mechanism of Cervical Carcinogenesis Based on Systems Biology Technologies.Comput Struct Biotechnol J2019https://conductscience.org/library/papers/30847042PubMed
109,865,919Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array.Clin Cancer Res1998https://conductscience.org/library/papers/9865919PubMed

1 to 10 of 24

See all 24 references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
41,588,777Exploring Molecular Signature and Prognostic Biomarkers in Ovarian Cancer: Insights From Late-Stage, Recurrent, and Metastatic Tumors.Biotechnol Appl Biochem2026https://conductscience.org/library/papers/41588777PubMed
41,373,619Fueling the Seed: Growth Factors and Cytokines Driving Cancer Stem Cells in Gynecological Malignancies.Int J Mol Sci2025https://conductscience.org/library/papers/41373619PubMed
38,988,712Elucidating prognosis in cervical squamous cell carcinoma and endocervical adenocarcinoma: a novel anoikis-related gene signature model.Front Oncol2024https://conductscience.org/library/papers/38988712PubMed
38,533,261Potential pharmacological mechanisms of tanshinone IIA in the treatment of human neuroblastoma based on network pharmacological and molecular docking Technology.Front Pharmacol2024https://conductscience.org/library/papers/38533261PubMed
37,091,377Total Chemical Synthesis of Palmitoyl-Conjugated Insulin.ACS Omega2023https://conductscience.org/library/papers/37091377PubMed
35,899,233A Potent EGFR Inhibitor, N-Phenyl Pyrazoline Derivative Suppresses Aggressiveness and Cancer Stem Cell-Like Phenotype of Cervical Cancer Cells.Drug Des Devel Ther2022https://conductscience.org/library/papers/35899233PubMed
34,551,673miR-186-3p attenuates the tumorigenesis of cervical cancer via targeting insulin-like growth factor 1 to suppress PI3K-Akt signaling pathway.Bioengineered2021https://conductscience.org/library/papers/34551673PubMed
32,899,449Effects of IGF-1 on Proliferation, Angiogenesis, Tumor Stem Cell Populations and Activation of AKT and Hedgehog Pathways in Oral Squamous Cell Carcinoma.Int J Mol Sci2020https://conductscience.org/library/papers/32899449PubMed

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
IGF13,479PubTator's text mininghttps://conductscience.org/library/genes/3479NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32602015

GET https://conductscience.org/api/papers/v1/32602015/references?page=2

API referenceFor AI assistants